Assunta Cirella

1.7k total citations
26 papers, 545 citations indexed

About

Assunta Cirella is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Assunta Cirella has authored 26 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 17 papers in Immunology and 5 papers in Genetics. Recurrent topics in Assunta Cirella's work include CAR-T cell therapy research (15 papers), Immunotherapy and Immune Responses (11 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Assunta Cirella is often cited by papers focused on CAR-T cell therapy research (15 papers), Immunotherapy and Immune Responses (11 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Assunta Cirella collaborates with scholars based in Spain, United Kingdom and Italy. Assunta Cirella's co-authors include Ignacio Melero, Pedro Berraondo, Álvaro Teijeira, Irene Olivera, Saray Garasa, María C. Ochoa, Miguel F. Sanmamed, Iñaki Eguren‐Santamaría, Carlos E. de Andrea and Kurt A. Schalper and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Assunta Cirella

26 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Assunta Cirella Spain 13 322 235 148 49 47 26 545
Karen O. Dixon United States 12 639 2.0× 397 1.7× 182 1.2× 36 0.7× 31 0.7× 20 884
Ana Carolina Leal Brazil 8 270 0.8× 158 0.7× 272 1.8× 45 0.9× 25 0.5× 20 601
Anjana Ranganathan United States 6 487 1.5× 402 1.7× 152 1.0× 29 0.6× 33 0.7× 11 783
Aïda Meghraoui France 12 368 1.1× 165 0.7× 141 1.0× 28 0.6× 32 0.7× 16 549
Yi‐Jou Tai Taiwan 11 210 0.7× 260 1.1× 133 0.9× 42 0.9× 12 0.3× 35 561
Ilia N. Buhtoiarov United States 15 614 1.9× 409 1.7× 164 1.1× 20 0.4× 29 0.6× 30 812
Anne Kathrin Volkmer Germany 10 514 1.6× 246 1.0× 195 1.3× 120 2.4× 38 0.8× 14 905
Haizhou Xing China 11 180 0.6× 208 0.9× 192 1.3× 29 0.6× 25 0.5× 31 561
Qianshan Tao China 16 362 1.1× 310 1.3× 156 1.1× 15 0.3× 41 0.9× 58 641
Mattia Algeri Italy 16 210 0.7× 225 1.0× 174 1.2× 66 1.3× 96 2.0× 55 685

Countries citing papers authored by Assunta Cirella

Since Specialization
Citations

This map shows the geographic impact of Assunta Cirella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Assunta Cirella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Assunta Cirella more than expected).

Fields of papers citing papers by Assunta Cirella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Assunta Cirella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Assunta Cirella. The network helps show where Assunta Cirella may publish in the future.

Co-authorship network of co-authors of Assunta Cirella

This figure shows the co-authorship network connecting the top 25 collaborators of Assunta Cirella. A scholar is included among the top collaborators of Assunta Cirella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Assunta Cirella. Assunta Cirella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olivera, Irene, Assunta Cirella, Myriam Fernández-Sendin, et al.. (2023). Intraperitoneal administration of a modified vaccinia virus Ankara confers single-chain interleukin-12 expression to the omentum and achieves immune-mediated efficacy against peritoneal carcinomatosis. Journal for ImmunoTherapy of Cancer. 11(11). e006702–e006702. 8 indexed citations
2.
Olivera, Irene, Elixabet Bolaños, Sandra Hervás‐Stubbs, et al.. (2023). mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy. Cell Reports Medicine. 4(3). 100978–100978. 32 indexed citations
3.
Álvarez, Maite, Carmen Molina, Saray Garasa, et al.. (2023). Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic. OncoImmunology. 12(1). 2197370–2197370. 10 indexed citations
4.
Ochoa, María C., Carlos E. de Andrea, Saray Garasa, et al.. (2023). Synergistic effects of combined immunotherapy strategies in a model of multifocal hepatocellular carcinoma. Cell Reports Medicine. 4(4). 101009–101009. 16 indexed citations
5.
Cirella, Assunta, Elixabet Bolaños, Carlos Luri‐Rey, et al.. (2023). Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists. Molecular Therapy — Nucleic Acids. 33. 668–682. 6 indexed citations
6.
Melero, Ignacio, María C. Ochoa, Carmen Molina, et al.. (2023). Intratumoral co‐injection of NK cells and NKG2A ‐neutralizing monoclonal antibodies. EMBO Molecular Medicine. 15(11). e17804–e17804. 13 indexed citations
7.
Cirella, Assunta, Myriam Fernández-Sendin, Irene Olivera, et al.. (2022). Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8 + T cells eradicates peritoneal metastases in mouse models. OncoImmunology. 12(1). 2147317–2147317. 9 indexed citations
8.
Glez‐Vaz, Javier, Arantza Azpilikueta, Irene Olivera, et al.. (2022). Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies. Journal for ImmunoTherapy of Cancer. 10(3). e003532–e003532. 13 indexed citations
9.
Teijeira, Álvaro, Saray Garasa, Carlos Luri‐Rey, et al.. (2022). Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy. Cancer Research. 82(23). 4373–4385. 22 indexed citations
10.
Cirella, Assunta, Myriam Fernández-Sendin, Inmaculada Rodríguez, et al.. (2022). Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis. OncoImmunology. 11(1). 2098657–2098657. 2 indexed citations
11.
Cirella, Assunta, Carlos Luri‐Rey, Álvaro Teijeira, et al.. (2022). Novel strategies exploiting interleukin-12 in cancer immunotherapy. Pharmacology & Therapeutics. 239. 108189–108189. 74 indexed citations
12.
Glez‐Vaz, Javier, Arantza Azpilikueta, Irene Olivera, et al.. (2022). Abstract 628: Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies. Cancer Research. 82(12_Supplement). 628–628. 1 indexed citations
13.
Olivera, Irene, Elixabet Bolaños, Sandra Hervás‐Stubbs, et al.. (2022). 267 mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy. Regular and Young Investigator Award Abstracts. A282–A282. 1 indexed citations
14.
Cirella, Assunta, et al.. (2022). Overcoming the limitations of cytokines to improve cancer therapy. International review of cell and molecular biology. 369. 107–141. 14 indexed citations
15.
Fernández-Sendin, Myriam, Assunta Cirella, Álvaro Teijeira, et al.. (2021). Mouse Models of Peritoneal Carcinomatosis to Develop Clinical Applications. Cancers. 13(5). 963–963. 12 indexed citations
16.
Teijeira, Álvaro, Saray Garasa, María C. Ochoa, et al.. (2021). Differential Interleukin‐8 thresholds for chemotaxis and netosis in human neutrophils. European Journal of Immunology. 51(9). 2274–2280. 41 indexed citations
17.
Fernández-Sendin, Myriam, Assunta Cirella, Irene Olivera, et al.. (2021). Advances in mRNA-based drug discovery in cancer immunotherapy. Expert Opinion on Drug Discovery. 17(1). 41–53. 18 indexed citations
18.
Teijeira, Álvaro, Saray Garasa, María C. Ochoa, et al.. (2020). IL8, Neutrophils, and NETs in a Collusion against Cancer Immunity and Immunotherapy. Clinical Cancer Research. 27(9). 2383–2393. 162 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen O. Dixon Breakdown of academic impact, for papers by Ana Carolina Leal Breakdown of academic impact, for papers by Anjana Ranganathan Breakdown of academic impact, for papers by Aïda Meghraoui Breakdown of academic impact, for papers by Yi‐Jou Tai Breakdown of academic impact, for papers by Ilia N. Buhtoiarov Breakdown of academic impact, for papers by Anne Kathrin Volkmer Breakdown of academic impact, for papers by Haizhou Xing Breakdown of academic impact, for papers by Qianshan Tao Breakdown of academic impact, for papers by Mattia Algeri
Rankless by CCL
2026